ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Rooting Out CRS Causes Is Cause for Debate

by Thomas R. Collins • June 1, 2009

  • Tweet
  • Email
Print-Friendly Version

PHILADELPHIA-It is generally accepted that foreign microbial antigens drive the inflammation in chronic rhinosinusitis. Which antigens are responsible, though, is not certain. But researchers are trying to find out.

You Might Also Like

  • The Etiology of Chronic Rhinosinusitis Remains Unclear
  • Saline Irrigation Effective in Treating CRS
  • ESS Provides Better QOL for CRS Patients with Comorbid Migraine
  • Eosinophilic Esophagitis, CRS Show Associations as Comorbid Conditions
Explore This Issue
June 2009

At Rhinology World 2009, two experts in the field debated the causes of the disease and discussed the prospect of homing on better treatments. But even as they did so, they acknowledged that the way the patient reacts to the antigens ultimately causes the problem.

Jens Ponikau, MD, Assistant Professor of Clinical Otolaryngology at the State University of New York-Buffalo, pointed to eosinophils in making his case that fungi are at the heart of chronic rhinosinusitis, a group of disorders involving inflammation of the mucus of the nose and paranasal sinuses, lasting at least 12 weeks.

Figure. An eosinophil (yellow) degranulates on a piece of fungus (red) and attacks it by smearing its toxic protein (major basic protein, green) onto the fungus.

click for large version
Figure. An eosinophil (yellow) degranulates on a piece of fungus (red) and attacks it by smearing its toxic protein (major basic protein, green) onto the fungus.

Robert Kern, MD, Professor and Chairman of the Department of Otolaryngology-Head and Neck Surgery at the Northwestern University Feinberg School of Medicine in Chicago, argued that the evidence pointing to fungi as the main instigators is thin.

Eosinophils Provide Evidence for Fungi

Dr. Ponikau’s research has shown how eosinophils, which are the main inflammatory agent, attack fungi in patients with CRS. He also pointed out studies showing positive results from antifungal medications in combating the disease.

In a video, he showed eosinosphils tearing apart fungal germinating spores when they were stimulated with a signal coming from the lymphocytes of CRS patients. You can nicely see how the eosinophils start to target the fungi, he said. You can see they don’t bother about the hyphae [the mature segment]. They’re going after the germinating spores [which secrete the antigen].

When lymphocytes from healthy controls were used, the eosinophils didn’t get the attack signal and did not react the same way. The eosinophils kind of sniff on there a little bit…and walk away again, Dr. Ponikau said. No attack.

He added, Believe it or not, this became the difference between a patient who had CRS and a healthy person.

Dr. Ponikau’s research has shown that the production by patients’ lymphocytes of interleukin (IL)-5, a key cytokine that activates and prolongs the life of eosinophils, is instigated by the presence of the fungus Alternaria. The same is true with the cytokine IL-13, which is key to recruiting the eosinophils to the sinus tissue. The key was that only patients with CRS were reacting, but healthy controls did not react to the fungi by producing these, he said.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Rhinology Tagged With: chronic rhinosinusitis, diagnosis, fungus, microbe, treatmentIssue: June 2009

You Might Also Like:

  • The Etiology of Chronic Rhinosinusitis Remains Unclear
  • Saline Irrigation Effective in Treating CRS
  • ESS Provides Better QOL for CRS Patients with Comorbid Migraine
  • Eosinophilic Esophagitis, CRS Show Associations as Comorbid Conditions

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Did You Receive COVID-19 Relief? Here Are Reporting Considerations for 2021
    • Otolaryngology Experts Share Best Practices in Five Areas
    • How Climate Change May Be Affecting Sleep Patterns for Adults and Children
    • Laryngologists Discuss Tough Tracheostomy Choices During COVID-19 Era
    • Head and Neck Cancer: Experts Discuss How to Improve Surgery Quality and Value

Polls

Did you receive funding from the CARES Act or Paycheck Protection Program?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.